CS logo
small CS logo
Department of Oncology,National Taiwan University Hospital

Taipei, Taiwan
Hospital in Taipei
No. 7號, Zhongshan S Rd, Zhongzheng District, Taipei City, 100
2,400 Beds

About Department of Oncology,National Taiwan University Hospital


The National Taiwan University Hospital is a medical facility located in the Zhongzheng District of Taipei, Taiwan. It started operations under Japanese rule in Daitōtei on 18 June 1895, and moved to its present location in 1898.
There are 2,400 beds in Department of Oncology,National Taiwan University Hospital.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Department of Oncology,National Taiwan University Hospital


During the past decade, Department of Oncology,National Taiwan University Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Oncology,National Taiwan University Hospital" #1 collaborator was "Taipei Veterans General Hospital, Taiwan" with 2 trials as a collaborator, "Chang Gung Memorial Hospital" with 1 trials as a collaborator, "Far Eastern Memorial Hospital" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "National Cheng-Kung University Hospital" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

Clinical Trials Conditions at Department of Oncology,National Taiwan University Hospital


According to Clinical.Site data, the most researched conditions in "Department of Oncology,National Taiwan University Hospital" are "Non-Small Cell Lung Cancer" (3 trials), "Breast Cancer" (2 trials), "Gastric Cancer" (2 trials), "Non-small Cell Lung Cancer (NSCLC)" (2 trials) and "Non-small Cell Lung Cancer(NSCLC)" (2 trials). Many other conditions were trialed in "Department of Oncology,National Taiwan University Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Department of Oncology,National Taiwan University Hospital


Most popular intervention types in "Department of Oncology,National Taiwan University Hospital" are "Drug" (22 trials), "Procedure" (4 trials), "Behavioral" (1 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "5% DW perineural injection" (1 trials), "5-Fluorouracil, Leucovorin" (1 trials), "A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Advanced Thyroid Cancer Patients" (1 trials), "AUY922" (1 trials) and "Afatinib" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Department of Oncology,National Taiwan University Hospital


The vast majority of trials in "Department of Oncology,National Taiwan University Hospital" are 27 trials for "All" genders and 3 trials for "Female" genders.

Clinical Trials Status at Department of Oncology,National Taiwan University Hospital


Currently, there are NaN active trials in "Department of Oncology,National Taiwan University Hospital". undefined are not yet recruiting, 7 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Department of Oncology,National Taiwan University Hospital, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Department of Oncology,National Taiwan University Hospital, 3 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".